InterCure Stock (NASDAQ:INCR)

Revenue Ownership Financials Chart

Previous Close

$1.34

52W Range

$1.17 - $3.72

50D Avg

$1.53

200D Avg

$2.14

Market Cap

$68.19M

Avg Vol (3M)

$34.65K

Beta

0.03

Div Yield

INCR Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

270

IPO Date

Jan 28, 2019

Website

INCR Performance

INCR Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$355.55M	$388.68M	$219.68M
Operating Income	$-40.90M	$52.80M	$28.19M
Net Income	$-61.96M	$44.82M	$7.30M
EBITDA	$-27.74M	$64.50M	$37.58M
Basic EPS	$-1.36	$0.99	$0.16
Diluted EPS	$-1.36	$0.99	$0.16

Fiscal year ends in Dec 23 | Currency in ILS

Latest Earnings Call Transcripts

Q4 22Apr 04, 23 | 6:56 PM

Q2 22Aug 16, 22 | 2:11 PM

Q1 22May 17, 22 | 5:06 PM

Peer Comparison

Ticker	Company
PAHC	Phibro Animal Health Corporation
RGC	Regencell Bioscience Holdings Limited
IXHL	Incannex Healthcare Limited
PCRX	Pacira BioSciences, Inc.
PBH	Prestige Consumer Healthcare Inc.
COLL	Collegium Pharmaceutical, Inc.